Matthew Wook Chang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Matthew Wook Chang has a total of 286 co-authors. Here are the top co-authors by number of shared publications:
- Jee Loon Foo
NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore; Synthetic Biology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; National Centre for Engineering Biology (NCEB), Singapore
21 shared publications - Hua Ling
Shanghai Jiao Tong University
18 shared publications - In Young Hwang
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117596, Singapore
13 shared publications Nikhil Aggarwal
Affiliations NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore, Synthetic Biology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, National Centre for Engineering Biology (NCEB), Singapore, Singapore
12 shared publications- Yung Seng Lee
Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
10 shared publications In Young Hwang
Affiliations NUS Synthetic Biology for Clinical and Technological Innovation (SynCTI), National University of Singapore, Singapore, Singapore, Synthetic Biology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
9 shared publications
Latest Publications
- Open Access
- 4 October 2026
- Published by Wiley in Advanced Science
Conjugated Polymer‐Microbe Interactions Trigger Regulatory Reprogramming for Enhanced Bioelectrocatalysis
Abiotic redox‐active materials are increasingly used to interface with electroactive microorganisms, yet their influence on cellular regulation remains poorly understood. Here, Shewanella oneidensis MR‐1 was coupled with the electron‐transporting conjugated polymer poly(benzodifurandione) (PBFDO) to examine how material interfaces reshape inward extracellular electron transfer (EET). PBFDO‐coated carbon electrodes enhanced electron uptake and fumarate reduction, producing over two orders of magnitude higher current density and up to a twelvefold increase in succinate production than polymer‐free controls. Integrated electrochemical, transcriptomic, metabolomic, and protein analyses reveal coordinated physiological remodeling associated with the polymer‐supported interface rather than passive conductivity alone. PBFDO exposure is associated with transcriptional enrichment of genes linked to the Mtr‐CymA electron‐transfer conduit, energy metabolism, and biofilm formation. Metabolomics revealed altered intracellular redox and metabolite profiles consistent with enhanced fumarate respiration, alongside elevated NADH/NAD + and ATP/ADP ratios indicative of altered cellular redox and energetic states. Beyond transcriptional regulation, polymer‐responsive small RNAs (sRNAs) revealed a post‐transcriptional regulatory layer linked to the biohybrid interface. Delivery of individual sRNAs into control cells partially recapitulated the polymer‐induced phenotype, increasing current output up to threefold while altering intracellular redox balance. These findings establish sRNA‐mediated regulation as a previously unrecognized mechanism linking biohybrid interfaces to enhanced microbial electrosynthesis.
- 4 October 2026
- Published by Wiley in Advanced Science
Open AccessConjugated Polymer‐Microbe Interactions Trigger Regulatory Reprogramming for Enhanced Bioelectrocatalysis
Abiotic redox‐active materials are increasingly used to interface with electroactive microorganisms, yet their influence on cellular regulation remains poorly understood. Here, Shewanella oneidensis MR‐1 was coupled with the electron‐transporting conjugated polymer poly(benzodifurandione) (PBFDO) to examine how material interfaces reshape inward extracellular electron transfer (EET). PBFDO‐coated carbon electrodes enhanced electron uptake and fumarate reduction, producing over two orders of magnitude higher current density and up to a twelvefold increase in succinate production than polymer‐free controls. Integrated electrochemical, transcriptomic, metabolomic, and protein analyses reveal coordinated physiological remodeling associated with the polymer‐supported interface rather than passive conductivity alone. PBFDO exposure is associated with transcriptional enrichment of genes linked to the Mtr‐CymA electron‐transfer conduit, energy metabolism, and biofilm formation. Metabolomics revealed altered intracellular redox and metabolite profiles consistent with enhanced fumarate respiration, alongside elevated NADH/NAD + and ATP/ADP ratios indicative of altered cellular redox and energetic states. Beyond transcriptional regulation, polymer‐responsive small RNAs (sRNAs) revealed a post‐transcriptional regulatory layer linked to the biohybrid interface. Delivery of individual sRNAs into control cells partially recapitulated the polymer‐induced phenotype, increasing current output up to threefold while altering intracellular redox balance. These findings establish sRNA‐mediated regulation as a previously unrecognized mechanism linking biohybrid interfaces to enhanced microbial electrosynthesis.
- Open Access
- 25 August 2026
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 24 (8) , e3003926
Engineering inter-kingdom adrenergic signaling in commensals couples host stress hormone sensing to programmable biological outputs
Host stress is associated with elevated catecholamine neurohormones that influence gut physiology and host–microbe interactions, yet how bacterial systems detect and interpret these signals remains incompletely understood. Enteric pathogens exploit inter-kingdom adrenergic signaling to sense host-derived norepinephrine and epinephrine, but whether such pathways can be rationally rewired to produce predictable, programmable outputs has not been systematically explored. Here, we reconstitute adrenergic signaling in Escherichia coli Nissle 1917 by repurposing the enterohemorrhagic E. coli QseBC two-component system. Transcriptomic profiling revealed robust catecholamine-dependent activation of QseBC-regulated pathways in the engineered strain. Guided by these data, we redesigned a QseBC-responsive promoter through rational truncation, sigma-factor replacement, and optimization of QseBC expression, generating a synthetic promoter with enhanced sensitivity and dose-dependent responsiveness to stress hormones. Structure-guided mutagenesis of the QseC sensor kinase identified key residues required for catecholamine recognition, providing mechanistic insight into adrenergic hormone sensing. To demonstrate functional signal transduction beyond transcriptional reporting, we coupled the sensing module to a secretion cassette encoding a corticotropin-releasing factor (CRF) receptor antagonist as a model bioactive output and validated bioactivity in vitro. Together, this work elucidates principles governing bacterial stress hormone sensing and demonstrates how inter-kingdom signaling pathways can be engineered to yield programmable biological outputs.
- 25 August 2026
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 24 (8) , e3003926
Open AccessEngineering inter-kingdom adrenergic signaling in commensals couples host stress hormone sensing to programmable biological outputs
Host stress is associated with elevated catecholamine neurohormones that influence gut physiology and host–microbe interactions, yet how bacterial systems detect and interpret these signals remains incompletely understood. Enteric pathogens exploit inter-kingdom adrenergic signaling to sense host-derived norepinephrine and epinephrine, but whether such pathways can be rationally rewired to produce predictable, programmable outputs has not been systematically explored. Here, we reconstitute adrenergic signaling in Escherichia coli Nissle 1917 by repurposing the enterohemorrhagic E. coli QseBC two-component system. Transcriptomic profiling revealed robust catecholamine-dependent activation of QseBC-regulated pathways in the engineered strain. Guided by these data, we redesigned a QseBC-responsive promoter through rational truncation, sigma-factor replacement, and optimization of QseBC expression, generating a synthetic promoter with enhanced sensitivity and dose-dependent responsiveness to stress hormones. Structure-guided mutagenesis of the QseC sensor kinase identified key residues required for catecholamine recognition, providing mechanistic insight into adrenergic hormone sensing. To demonstrate functional signal transduction beyond transcriptional reporting, we coupled the sensing module to a secretion cassette encoding a corticotropin-releasing factor (CRF) receptor antagonist as a model bioactive output and validated bioactivity in vitro. Together, this work elucidates principles governing bacterial stress hormone sensing and demonstrates how inter-kingdom signaling pathways can be engineered to yield programmable biological outputs.
- Open Access
- 3 August 2026
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 58 (8) , 2417-2429
Autonomous intranasal delivery systems for central nervous system therapeutics
Intranasal delivery provides a rapid, non-invasive route to the central nervous system, bypassing the blood–brain barrier and first-pass metabolism. However, its therapeutic potential remains constrained by the nasal cavity’s complex anatomy, the restricted surface area and permeability of the olfactory epithelium, and short drug residence times. Recent advances in nanotechnology and synthetic biology have enabled the development of autonomous and programmable delivery systems that can target the olfactory epithelium, enhance brain entry and sustain therapeutic release. This review highlights current strategies for engineering intranasal drug delivery vectors that can replicate or extend cellular functions to enable autonomous nose-to-brain drug delivery. These vectors include: synthetic nanoparticles that mimic essential cellular activities and allow for modular surface modification; extracellular vesicles that naturally carry therapeutic cargo and exhibit parent-cell-derived tropism; and living therapeutics, such as engineered microbes, viruses or stem cells, that respond dynamically to host environments and can be genetically programmed for precise payload production. Emphasis is placed on the modular design of functional components, host-responsive interactions tailored to anatomical and physiological cues, and the integration of programmable functions that collectively drive delivery autonomy and therapeutic efficacy. Together, these advances position intranasal delivery as a versatile platform for treating neurological disorders, offering a foundation for future translational development.
- 3 August 2026
- Published by Springer Nature in Experimental & Molecular Medicine
- Vol. 58 (8) , 2417-2429
Open AccessAutonomous intranasal delivery systems for central nervous system therapeutics
Intranasal delivery provides a rapid, non-invasive route to the central nervous system, bypassing the blood–brain barrier and first-pass metabolism. However, its therapeutic potential remains constrained by the nasal cavity’s complex anatomy, the restricted surface area and permeability of the olfactory epithelium, and short drug residence times. Recent advances in nanotechnology and synthetic biology have enabled the development of autonomous and programmable delivery systems that can target the olfactory epithelium, enhance brain entry and sustain therapeutic release. This review highlights current strategies for engineering intranasal drug delivery vectors that can replicate or extend cellular functions to enable autonomous nose-to-brain drug delivery. These vectors include: synthetic nanoparticles that mimic essential cellular activities and allow for modular surface modification; extracellular vesicles that naturally carry therapeutic cargo and exhibit parent-cell-derived tropism; and living therapeutics, such as engineered microbes, viruses or stem cells, that respond dynamically to host environments and can be genetically programmed for precise payload production. Emphasis is placed on the modular design of functional components, host-responsive interactions tailored to anatomical and physiological cues, and the integration of programmable functions that collectively drive delivery autonomy and therapeutic efficacy. Together, these advances position intranasal delivery as a versatile platform for treating neurological disorders, offering a foundation for future translational development.
- 30 June 2026
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 100, 103547
Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design
- 30 June 2026
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 100, 103547
Microbial C1 assimilation pathways for chemical synthesis: from native metabolism to synthetic design
- 26 May 2026
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (7) , 1084-1088
A framework for building a synthetic cell from the SynCell Asia Initiative
- 26 May 2026
- Published by Springer Nature in Nature Biotechnology
- Vol. 44 (7) , 1084-1088
A framework for building a synthetic cell from the SynCell Asia Initiative
- 28 April 2026
- Published by Springer Nature in Nature Catalysis
- Vol. 9 (5) , 502-515
Single-particle imaging uncovers reverse electron transfer efficiency between Shewanella oneidensis MR-1 and shaped haematite
- 28 April 2026
- Published by Springer Nature in Nature Catalysis
- Vol. 9 (5) , 502-515
Single-particle imaging uncovers reverse electron transfer efficiency between Shewanella oneidensis MR-1 and shaped haematite
- Open Access
- 28 March 2026
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 91, 102748
Microbial chassis selection for niche-specific engineered live biotherapeutics
- 28 March 2026
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 91, 102748
Open AccessMicrobial chassis selection for niche-specific engineered live biotherapeutics
- 22 December 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (1) , 9-23
Machine Learning in Microbiome Research and Engineering
Microbiomes, complex communities of microorganisms and their genetic material, hold immense potential for addressing global challenges in diverse sectors, including healthcare, agriculture, and bioproduction. Engineering these intricate ecosystems, however, necessitates a comprehensive understanding of the complex web of microbial interactions. The emergence of machine learning (ML) has revolutionized microbiome research, offering powerful tools to analyze massive data sets, uncover hidden patterns, and predict microbial behavior. ML algorithms have demonstrated remarkable success in identifying and characterizing microbial communities, predicting interactions between organisms and optimizing the design of microbial communities for specific functions. This Perspective examines the transformative applications of ML in the context of microbiome engineering, encompassing both microbiome data analysis and the targeted manipulation of microbial communities. These techniques employ a variety of strategies, including the manipulation of quorum sensing molecules, antimicrobial peptides, growth conditions, the introduction of probiotics, and the utilization of bacteriophages. By integrating ML with experimental approaches, researchers are pushing the boundaries of microbiome engineering, paving the way for novel applications in diverse fields. However, it is important to acknowledge the challenges that ML algorithms face, such as the limited availability of high-quality, large-scale data sets, the inherent complexity of biological systems, and the need for improved integration of experimental and computational methods. This perspective further discusses the future perspectives of the field, highlighting expected developments in data generation, algorithm development, and interdisciplinary collaboration. These advancements hold the key to unlocking the full potential of microbial communities for addressing pressing global challenges.
- 22 December 2025
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 15 (1) , 9-23
Machine Learning in Microbiome Research and Engineering
Microbiomes, complex communities of microorganisms and their genetic material, hold immense potential for addressing global challenges in diverse sectors, including healthcare, agriculture, and bioproduction. Engineering these intricate ecosystems, however, necessitates a comprehensive understanding of the complex web of microbial interactions. The emergence of machine learning (ML) has revolutionized microbiome research, offering powerful tools to analyze massive data sets, uncover hidden patterns, and predict microbial behavior. ML algorithms have demonstrated remarkable success in identifying and characterizing microbial communities, predicting interactions between organisms and optimizing the design of microbial communities for specific functions. This Perspective examines the transformative applications of ML in the context of microbiome engineering, encompassing both microbiome data analysis and the targeted manipulation of microbial communities. These techniques employ a variety of strategies, including the manipulation of quorum sensing molecules, antimicrobial peptides, growth conditions, the introduction of probiotics, and the utilization of bacteriophages. By integrating ML with experimental approaches, researchers are pushing the boundaries of microbiome engineering, paving the way for novel applications in diverse fields. However, it is important to acknowledge the challenges that ML algorithms face, such as the limited availability of high-quality, large-scale data sets, the inherent complexity of biological systems, and the need for improved integration of experimental and computational methods. This perspective further discusses the future perspectives of the field, highlighting expected developments in data generation, algorithm development, and interdisciplinary collaboration. These advancements hold the key to unlocking the full potential of microbial communities for addressing pressing global challenges.
- Open Access
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-6
Abstraction hierarchy to define biofoundry workflows and operations for interoperable synthetic biology research and applications
Lack of standardization in biofoundries limits the scalability and efficiency of synthetic biology research. Here, we propose an abstraction hierarchy that organizes biofoundry activities into four interoperable levels: Project, Service/Capability, Workflow, and Unit Operation, effectively streamlining the Design‑Build‑Test‑Learn (DBTL) cycle. This framework enables more modular, flexible, and automated experimental workflows. It improves communication between researchers and systems, supports reproducibility, and facilitates better integration of software tools and artificial intelligence. Our approach lays the foundation for a globally interoperable biofoundry network, advancing collaborative synthetic biology and accelerating innovation in response to scientific and societal challenges.
- 1 July 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-6
Open AccessAbstraction hierarchy to define biofoundry workflows and operations for interoperable synthetic biology research and applications
Lack of standardization in biofoundries limits the scalability and efficiency of synthetic biology research. Here, we propose an abstraction hierarchy that organizes biofoundry activities into four interoperable levels: Project, Service/Capability, Workflow, and Unit Operation, effectively streamlining the Design‑Build‑Test‑Learn (DBTL) cycle. This framework enables more modular, flexible, and automated experimental workflows. It improves communication between researchers and systems, supports reproducibility, and facilitates better integration of software tools and artificial intelligence. Our approach lays the foundation for a globally interoperable biofoundry network, advancing collaborative synthetic biology and accelerating innovation in response to scientific and societal challenges.